STRATA Skin Sciences, Inc. (SSKN)

USD 3.0

(-1.64%)

Market Cap (In USD)

12.51 Million

Revenue (In USD)

33.35 Million

Net Income (In USD)

-10.83 Million

Avg. Volume

25.54 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.51-6.5
PE
-
EPS
-
Beta Value
1.323
ISIN
US86272A2069
CUSIP
86272A206
CIK
1051514
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Dolev Rafaeli Ph.D.
Employee Count
-
Website
https://www.strataskinsciences.com
Ipo Date
2005-11-03
Details
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.